97383276 - EIRGEN

Information

• Trademark
• 97383276

• Source

• Serial Number

  97383276

• Registration Number

  7172805

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  April 26, 2022
  3 years ago

• Registration Date

  September 26, 2023
  2 years ago

• Transaction Date

  September 26, 2023
  2 years ago

• Status Date

  September 26, 2023
  2 years ago

• Published for Opposition Date

  July 11, 2023
  2 years ago

• Location Date

  September 26, 2023
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MAJCHER HARTNETT, MEGA

• Attorney Docket Number

  T101-US0016

  Attorney Name

  Sean P. McMahon

  Law Office Assigned Location Code

  N50

• Owners

  • Eirgen Pharma Ltd.

Case File Statements

• GS0051: Pharmaceutical preparations and substances for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; sanitary preparations for medical use; prescription pharmaceutical and biotechnological preparations for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; biological preparations for medical purposes, namely, for use in biotechnology for the treatment of cancer, infectious diseases, metabolic diseases and disorders; chemical preparations and reagents for use in biotechnology for medical and veterinary use, namely, renal diseases and disorders, cognitive and neurological disorders, vitamin D insufficiencies, cancer and infectious diseases; injectable solutions for medical purposes, namely, injectable pharmaceuticals for cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders; dietetic foods, namely, pasta, crackers, and bread, food supplements, infusions, drinks and beverages all adapted for medical use; all purpose disinfectants, oral disinfectants for medical and hygienic purposes, disinfectants for hygienic and sanitary purposes, disinfectants for medical instruments; syrups for pharmaceutical purposes, namely, cough syrups; vaccines; syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use; pre-filled disposable syringes and hypodermic syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use
• GS0011: Chemicals used in industry, science and photography; chemical substances for preserving foodstuffs; adhesives used in industry; biological preparations for use in biotechnology other than for medical use
• GS0421: The provision of information on the subject of research and development, drug development and product evaluation all in the field of pharmaceuticals and biotechnology; scientific and industrial research relating to pharmaceuticals and biotechnology

Case File Event Statements

• 9/26/2023 - 2 years ago

  19 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 9/26/2023 - 2 years ago

  18 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/11/2023 - 2 years ago

  17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/11/2023 - 2 years ago

  16 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/21/2023 - 2 years ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/7/2023 - 2 years ago

  14 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD

• 6/2/2023 - 2 years ago

  13 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 5/30/2023 - 2 years ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/26/2023 - 2 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/25/2023 - 2 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/25/2023 - 2 years ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/15/2023 - 2 years ago

  8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 5/15/2023 - 2 years ago

  7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 2/13/2023 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/13/2023 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/13/2023 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/13/2023 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 5/3/2022 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/29/2022 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP